Orrin Hatch

the overly partisan treatment of nominees and distortions of their records is a relatively new development on this committee.

I hope that my colleagues don't invent new standards for finances, ethics, and disclosure that are different from those that have generally applied in the past.

virtually all the attempts I've witnessed to characterize Dr. Price's views as being 'outside of the mainstream' have been absurd.

If they do not, it kind of says something about what is happening in this country.

This money does not grow on trees, and yet every one of us wants to make sure health care works.

I look forward to Dr. Price being confirmed and assuming his position.

I have never had a witness for any position in government who has performed as well as you have.

very upfront and very straightforward, very honest, and somebody who really understands the health-care system of this country.

When Obamacare was pushed through on a series of party-line votes, Republicans in Congress warned that the new health-care law basically would harm patients, families, and businesses.

We have to find some way of delivering all these health-care benefits to people without totally ruining the country.

You are going to do your doggone level best to make sure health care is delivered to our American people.

The position of Treasury Secretary is among the most important in the executive branch.

I want to make sure, first and foremost, that our trade policies do no harm.

Among my concerns with the Trans-Pacific Partnership, or TPP, agreement is the fact that it failed to prohibit local data storage requirements in the financial services sector.

I want to officially welcome Mr. Mnuchin to the Finance Committee.

It is absolutely essential that we have a cooperative partner overseeing Treasury.

I expect you to engage in much better consultations with the committee regarding U.S. trade policies than we have had under President Obama.

I have to commend Donald Trump for picking you.

the collapse of Obamacare has exacerbated our Nation's health care problems.

The Orphan Drug Act, which passed I think 30 years ago or so... has revolutionized the ability to treat rare diseases.

Despite these failed reforms, I don't think we can lose sight of the broader health system that is at risk.

Obamacare has not really helped.

Well, thank you, Mr. Chairman. Welcome to the committee. Having worked with you over the years, I found you to be always very, very knowledgeable.

We just put some incentives in effect, and all of a sudden there's an explosion in orphan drugs for populations of less than 200,000.

I appreciate your commitment to expanding opportunities for all children and your tireless work in the field of education.